Community-generated resource library-Summary Chart of U.S. Medical Eligibility Criteria for Contraceptive Use

Summary Chart of U.S. Medical Eligibility Criteria for Contraceptive Use - Color

Pdf Summary

The document provides an overview of the U.S. Medical Eligibility Criteria (MEC) for contraceptive use, primarily for health providers. These guidelines help determine the suitability of various contraceptive methods (such as Cu-IUD, LNG-IUD, implants, DMPA, POP, and CHC) for individuals with different health conditions. Key details include: 

1. <strong>Age Considerations</strong>: Recommendations vary by age group, with specific distinctions for ages menarche to 18-20 years and up to 45 years.

2. <strong>Health Conditions</strong>: Conditions like anatomical abnormalities, anemia, breast disease, kidney disease, diabetes, and more are considered. Specific criteria are provided for initiation (I) and continuation (C) of contraceptive methods.

3. <strong>Risk Levels</strong>: Conditions are categorized in order of risk, from '1' (no restriction) to '4' (unacceptable health risk).

4. <strong>Contraindications and Precautions</strong>: For example, breastfeeding mothers have specific guidelines postpartum, and individuals with a history of DVT or PE or certain chronic conditions (e.g., liver disease, hypertension) are advised based on risk level.

5. <strong>Contraception and HIV/STI</strong>: While most contraceptives don't protect against STIs, external (male) latex condoms can reduce risk.

6. <strong>Drug Interactions</strong>: Interactions with antiretrovirals (ARVs), anticonvulsants, and other drugs are detailed, emphasizing how these can affect contraceptive efficacy.

For comprehensive guidance, healthcare providers are directed to CDC and NIH links. This comprehensive chart aids in selecting appropriate contraceptive methods based on individual health profiles, ensuring patient safety and efficient reproductive health management.

Keywords

U.S. Medical Eligibility Criteria

contraceptive methods

health conditions

age considerations

risk levels

contraindications

HIV/STI prevention

drug interactions

healthcare providers

reproductive health